Last reviewed · How we verify
Sustained ventricular tachycardia
Approved treatments
- Norpace Cr · Pfizer
Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Sustained ventricular tachycardia patent landscape — cliff calendar, originator estates, attackable patents
- Sustained ventricular tachycardia treatment landscape brief
- Sustained ventricular tachycardia treatment updates RSS
Frequently asked questions about Sustained ventricular tachycardia
What drugs treat Sustained ventricular tachycardia?
Tracked treatments include Norpace Cr.
What is the treatment for Sustained ventricular tachycardia?
Standard treatment for Sustained ventricular tachycardia includes Norpace Cr. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Sustained ventricular tachycardia patent cliff · Sustained ventricular tachycardia CI report
- Treatment: Norpace Cr · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing